Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2021

Mar 15, 2021

31996_dirs_2021-03-15_2c1d15f4-394b-450f-9d35-162575f8fa08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-03-11

Reporting Person: Barnes Scott D (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-11 Common Stock M 2665 $15.25 Acquired 23055 Direct
2021-03-11 Common Stock D 2665 $92.00 Disposed 20390 Direct
2021-03-12 Common Stock M 2936 $0.00 Acquired 23326 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-11 Common Stock Options $15.25 M 2665 Disposed 2027-11-12 Common Stock (2665) Direct
2021-03-12 Common Stock Options $90.38 M 6207 Acquired 2031-03-11 Common Stock (6207) Direct

Footnotes

F1: Award of 2936 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24.

F2: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024.